Healthcare provider profile · identity verified

Conrad Frederic Schoenwald, DO

Family Practice · VACAVILLE, CA · NPI 1033374715

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	529	182
Atorvastatin Calcium	Atorvastatin Calcium	458	173
Losartan Potassium	Losartan Potassium	292	96
Hydrochlorothiazide	Hydrochlorothiazide	265	102
Albuterol Sulfate Hfa	Albuterol Sulfate	212	93
Levothyroxine Sodium	Levothyroxine Sodium	210	69
Lisinopril	Lisinopril	209	82
Metoprolol Succinate	Metoprolol Succinate	179	57
Tamsulosin Hcl	Tamsulosin Hcl	150	53
Metformin Hcl Er	Metformin Hcl	146	54
Famotidine	Famotidine	140	48
Fluticasone Propionate	Fluticasone Propionate	136	55
Buprenorphine	Buprenorphine	125	28
Atenolol	Atenolol	122	41
Azithromycin	Azithromycin	121	110
Gabapentin	Gabapentin	115	37
Wixela Inhub	Fluticasone Propion/Salmeterol	107	42
Cephalexin	Cephalexin	106	75
Trazodone Hcl	Trazodone Hcl	101	34
Metoprolol Tartrate	Metoprolol Tartrate	100	32
Simvastatin	Simvastatin	94	31
Paxlovid	Nirmatrelvir/Ritonavir	91	91
Pantoprazole Sodium	Pantoprazole Sodium	88	26
Amoxicillin	Amoxicillin	83	73
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	22
Metformin Hcl	Metformin Hcl	81	25
Fluoxetine Hcl	Fluoxetine Hcl	79	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	27
Triamcinolone Acetonide	Triamcinolone Acetonide	69	41
Finasteride	Finasteride	67	28
Allopurinol	Allopurinol	66	23
Tizanidine Hcl	Tizanidine Hcl	61	32
Hydroxyzine Hcl	Hydroxyzine Hcl	59	17
Escitalopram Oxalate	Escitalopram Oxalate	53	19
Furosemide	Furosemide	52	23
Montelukast Sodium	Montelukast Sodium	52	18
Terazosin Hcl	Terazosin Hcl	49	16
Glipizide Er	Glipizide	48	21
Lovastatin	Lovastatin	48	18
Prednisone	Prednisone	48	39
Duloxetine Hcl	Duloxetine Hcl	44	14
Pradaxa	Dabigatran Etexilate Mesylate	44	13
Ropinirole Hcl	Ropinirole Hcl	42	12
Omeprazole	Omeprazole	41	15
Ibuprofen	Ibuprofen	40	19
Mupirocin	Mupirocin	37	13
Clopidogrel	Clopidogrel Bisulfate	36	14
Humulin N	Insulin Nph Human Isophane	36	14
Sertraline Hcl	Sertraline Hcl	36	12
Colchicine	Colchicine	35	14
Doxycycline Monohydrate	Doxycycline Monohydrate	35	34
Bupropion Xl	Bupropion Hcl	34	17
Alendronate Sodium	Alendronate Sodium	33	14
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Naproxen	Naproxen	32	suppressed
Potassium Chloride	Potassium Chloride	32	15
Rosuvastatin Calcium	Rosuvastatin Calcium	32	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Alvesco	Ciclesonide	28	17
Spiriva Respimat	Tiotropium Bromide	28	12
Topiramate	Topiramate	28	suppressed
Carvedilol	Carvedilol	27	12
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Baclofen	Baclofen	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Lactulose	Lactulose	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Fluocinonide	Fluocinonide	19	suppressed
Glipizide	Glipizide	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	19	15
Ofloxacin	Ofloxacin	19	19
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	19	19
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Aripiprazole	Aripiprazole	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Lorazepam	Lorazepam	14	11
Amjevita(Cf) Autoinjector	Adalimumab-Atto	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Ozempic	Semaglutide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Digoxin	Digoxin	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Nystatin	Nystatin	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error